Tag: Vaccines

FDA Expanded Use of Tetanus, Diphtheria, Pertussis Vaccines

The U.S. Food and Drug Administration has approved the expanded use of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine Adsorbed) to include repeat vaccination...

Univercells Launches its Own Bioproduction System for Vaccines

The automated NevoLine bioproduction system that facilitates safer, faster and closed bioprocessing in a much smaller footprint. Univercells has launched its proprietary NevoLine bioproduction syst...

Researchers published the study on fractional-dose yellow fever vaccination

Researchers from Leiden University Medical Center studied 10 year data on a subgroup of patients from the trial to evaluate whether fractional-dose vaccination conferred long-term immunity.

Hong Kong stops vaccination service because of Sanofi-Aventis’ vaccines

malaria vaccine
Hong Kong's Department of Health as informed by Sanofi-Aventis, that it has decided to take a precautionary measure to suspend the supply of a batch of quadrivalent seasonal influenza vaccines.

EMA reviewed the tetravalent vaccine for prevention of dengue

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation for Dengvaxia (dengue tetravalent vaccine).

WHO expresses concern over measles outbreak in Europe

WHO is working closely with Member States currently facing outbreaks to implement response measures, including enhanced routine and supplemental immunization.

Russia may start using own quadrivalent influenza vaccine from 2019

The Head of Rospotrebnadzor noted that by September 1, about 50% of the required volume of vaccines would be delivered to the regions of the Russian Federation.

Scandal over low-quality vaccines flares out in China

The Jilin Food and Drug Administration revealed on its website that the second-largest drug manufacturer - Changchun Changsheng Life Sciences, in China provided defective vaccines for newborns.

Russia will introduce immunization against pneumococcal disease

influenza vaccine
Vaccination of adults over 55 years old against pneumococcal disease will be included in the National Immunization Schedule in 2020, said the Head of the Health Protection Committee at the State Duma.

EEC changed rules for registration of vaccines and use of GMP certificates

The Council of the Eurasian Economic Commission (EEC) has amended the rules for registration and expert examination of medicinal products for human use in the Eurasian Economic Union.

European Commission calls for cooperation on vaccine preventable diseases

European Commission (EC) issued a set of recommendations for how the EU can strengthen cooperation in the fight against diseases that can be prevented by vaccines.

WHO started anti-cholera vaccination campaign in Yemen

The World Health Organization (WHO), in cooperation with Yemeni local health authorities, has launched a wide-scale anti-cholera vaccination campaign in South Yemen.

EMA published its current recommendations for the influenza vaccines

influenza vaccine
The European Medicines Agency (EMA) has issued the EU recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2018.

Steering Group published their Manifesto for influenza vaccination in EU

influenza vaccine
The Steering Group on Influenza Vaccination has released their Manifesto calling for more action to increase seasonal influenza vaccination coverage rates in Europe to reduce the unacknowledged burden of this disease.

Nemaura Pharma moves forward with unique transdermal drug delivery technology

UK biotech company Nemaura Pharma has made significant progress in the reformulation of liquid vaccines administered through the skin using its solid dose delivery system, Micro-Patch

WHO approved Shantha Biotechnics cholera vaccine

Shantha Biotechnics, an affiliate of Sanofi Pasteur, has received approval from the World Health Organisation (WHO) for Shanchol, its oral cholera vaccine. The approval is for use at temperatures as h...